bpc-157 human clinical trial evidence review safety studies trials BPC-157 & The Gut-Brain Axis: A Practitioner's Definitive of the Evidence bpc-157 human clinical trials evidence – Regeneration or Risk? A Narrative – bpc-157 human clinical trials safety

Hunt A, Harrington D, Robinson S

By inhibiting NNMT and preserving NAD, 5-Amino-1MQ triggers a metabolic shift toward greater energy expenditure

[33] These are thought to be due to defective DNA synthesis inhibiting replication in tissue sites with a high turnover of cells

The failure of methionine synthesis due to cobalamin deficiency may either (1) lead to an accumulation of 5-methyl-tetrahydrofolate, trapping folate in a chemical form unusable in purine synthesis (the "folate trap" hypothesis) or (2) impair methylation reactions needed to produce formyl-tetrahydrofolate, a precursor to 5,10-methylene tetrahydrofolate